Conference Proceedings

A Phase 1 study of AK104, a tetrameric bispecific antibody that targets PD-1 and CTLA-4 in patients with advanced solid tumors

Ben Markman, Ben Tran, Hui Gan, Amy Prawira, Jermaine Coward, Xiaoping Jin, Baiyong Li, Max Wang, Yu Xia, Jayesh Desai, Michael Millward

JOURNAL FOR IMMUNOTHERAPY OF CANCER | BMC | Published : 2019